-+ 0.00%
-+ 0.00%
-+ 0.00%

aTyr Pharma Q4 EPS $(0.18) Beats $(0.23) Estimate

Benzinga·03/13/2025 20:11:09
Listen to the news
aTyr Pharma (NASDAQ:ATYR) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.23) by 21.74 percent. This is a 28 percent increase over losses of $(0.25) per share from the same period last year.